E86734 E8 Ruling Active

The tariff classification of Metipranolol (CAS-22664-55-7); Metoprolol Succinate (CAS-98418-47-4); Metoprolol Tartrate (56392-17-7); and Mexiletine Hydrochloride (5370-01-4), all imported in bulk form, from Slovakia

Issued December 8, 1999 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 2922.19.1800

Headings: 2922

Product description

We regret the delay in responding. According to Goodman & Gilman’ s The Pharmacological Basis of Therapeutics, Ninth Edition, the first product, Metipranolol, is a selective â-adrenergic antagonist used as a topical agent in the treatment of glaucoma. In addition, we note that the monograph for OptiPranolol® (metipranolol 0.3% ophthalmic solution), an ophthalmic medicament marketed by Bausch & Lomb®, states that “[O]ptiPranolol Ophthalmic Solution is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, including patients with ocular hypertension, and patients with chronic open angle glaucoma.” According to the 1999 Physicians’ Desk Reference®, the second and third products, Metoprolol Succinate and Metoprolol Tartrate, are both indicated for the treatment of hypertension, while the fourth product, Mexiletine Hydrochloride is indicated for the treatment of ventricular arrhythmias.

CBP rationale

The applicable subheading for all four products will be 2922.19.1800, Harmonized Tariff Schedule of the United States (HTS), which provides for "Oxygen- function amino-compounds: Amino-alcohols, their ethers and esters, other than those containing more than one kind of oxygen function, salts thereof: Other: Aromatic: Drugs: Other.

Full text

NY E86734 December 8, 1999 CLA-2-29:RR:NC:2:238 E86734 CATEGORY: Classification TARIFF NO.: 2922.19.1800 Ms. Erika Dominguez P.D.M. Pharmatec, Inc. 225 W. 34th Street, Suite 1307 New York, NY 10122 RE: The tariff classification of Metipranolol (CAS-22664-55-7); Metoprolol Succinate (CAS-98418-47-4); Metoprolol Tartrate (56392-17-7); and Mexiletine Hydrochloride (5370-01-4), all imported in bulk form, from Slovakia Dear Ms. Dominguez: In your letter dated June 17, 1999, you requested a tariff classification ruling. We regret the delay in responding. According to Goodman & Gilman’ s The Pharmacological Basis of Therapeutics, Ninth Edition, the first product, Metipranolol, is a selective â-adrenergic antagonist used as a topical agent in the treatment of glaucoma. In addition, we note that the monograph for OptiPranolol® (metipranolol 0.3% ophthalmic solution), an ophthalmic medicament marketed by Bausch & Lomb®, states that “[O]ptiPranolol Ophthalmic Solution is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, including patients with ocular hypertension, and patients with chronic open angle glaucoma.” According to the 1999 Physicians’ Desk Reference®, the second and third products, Metoprolol Succinate and Metoprolol Tartrate, are both indicated for the treatment of hypertension, while the fourth product, Mexiletine Hydrochloride is indicated for the treatment of ventricular arrhythmias. The applicable subheading for all four products will be 2922.19.1800, Harmonized Tariff Schedule of the United States (HTS), which provides for "Oxygen- function amino-compounds: Amino-alcohols, their ethers and esters, other than those containing more than one kind of oxygen function, salts thereof: Other: Aromatic: Drugs: Other." Pursuant to General Note 13, HTS, the rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

H80820 May 21, 2001

The tariff classification of Oxybutynin Chloride (CAS-1508-65-2), imported in bulk form, from France

F89977 August 8, 2000

The tariff classification of Phenyltoloxamine Citrate (CAS-1176-08-5), imported in bulk form, from India

F86532 May 3, 2000

The tariff classification of Bisoprolol Fumarate (CAS-104344-23-2) and Zolpidem Tartrate (CAS-99294-93-6), imported in bulk form, from Spain and Mexico, respectively

E89251 November 8, 1999

The tariff classification of Phenyltoloxamine Citrate (CAS-1176-08-5) and Sulfacetamide Sodium (CAS-127-56-0), imported in bulk form, from Switzerland

E84261 August 30, 1999

The tariff classification of Loratadine (CAS-79794-75-5) and Mexiletine Hydrochloride (5370-01-4), both imported in bulk form, from Slovakia

E80112 April 13, 1999

The tariff classification of Propoxyphene Napsylate (CAS No. 26570-10-5), imported in bulk form, from China

D87809 March 3, 1999

The tariff classification of Fluoxetine (CAS No. 54910-89-3), imported in bulk form, from Spain

D87813 March 3, 1999

The tariff classification of Fluoxetine Hydrochloride (CAS No. 59333-67-4), imported in bulk form, from Spain

D84831 January 7, 1999

The tariff classification of Tamoxifen Citrate (CAS-54965-24-1), imported in bulk form, from France; Imipramine Hydrochloride (CAS-113-52-0), imported in bulk form, from Italy; and Curezol 2MZA-PW (CAS-38668-46-1) from Japan

814353 August 31, 1995

The tariff classification of Tamoxifen citrate (CAS-54965-24-1), in bulk form, from the Netherlands

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →